Phase 2 Study of Selinexor and Bispecific Antibody for Treating Relapsed/Refractory Multiple Myeloma | Clinical Trial

Phase 2 Study of Selinexor and Bispecific Antibody for Treating Relapsed/Refractory Multiple Myeloma | Clinical Trial | Right2Hope